title: Neuroendocrine differentiation in prostate cancer: is it detectable and treatable?
authors.forename: A J
authors.initials: AJ
authors.lastname: Birtle
authors.forename: A
authors.initials: A
authors.lastname: Freeman
authors.forename: H A
authors.initials: HA
authors.lastname: Payne
authors.forename: J R W
authors.initials: JR
authors.lastname: Masters
authors.forename: S J
authors.initials: SJ
authors.lastname: Harland
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D053379:Chromogranin A; D002864:Chromogranins / Q000097:blood*; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood* / Q000473:pathology
chemical_list: D014408:Biomarkers, Tumor; D053379:Chromogranin A; D002864:Chromogranins; D017430:Prostate-Specific Antigen